Cur-Zyme
Natural health product licensed in Canada
- Other names
- CURCUMYALGIC
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80037907
- Status
- Inactive licence
- Licence date
- 29 November 2012
- Revision date
- 9 May 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3',4',5,7-pentahydroxyflavone Source : Gousse de Dimorphandra mollis Potency : 100 % Quercétine | 100 mg | Not calculated |
| Bromélaïne de tige Source : Ananas | 125 mg | Not calculated |
| Bromélaïne de tige Source : Tige(s) | 125 mg | Not calculated |
| Bromélaïne de tige Source : Ananas | 3,750,000 FCC PU | Not calculated |
| Bromélaïne de tige Source : Tige(s) | 3,750,000 FCC PU | Not calculated |
| Curcuma longa Source : Rhizome Extraction ratio : 60:1 Dry plant equivalent : 1,920 mg | 32 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae Potency : 24,000 UI Protéase | 40 mg | Not calculated |
Non-medicinal ingredients
bêta Cyclodextrin, Hypromellose, cellulose, Polysorbate 60
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
| Adultes | Not specified | 2 Capsule | 2 days |
Uses authorised in Canada
Utilisé comme anti-infiammatoire. Recommandé pour Ie traitement de I'ostéo-arthrite.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de sante si vous souffrez de calculs biliaires, d'obstructions biliaires, de lésions gastrointestinales ou si vous prenez des anticoagulants, anti-inflammatoires, antibiotiques ou avant de subir une chirurgie. Une allergie, de la nausée, vomissements et diarrée peuvent se manifester. Si tel est Ie cas, cesser I'utilisation. Ne pas utiliser si la bande sécuritaire est brisee. Garder hors de la portée des enfants. Entreposer dans un contenant à I'épreuve de la lumière.
- Contre-indications
Non recommandé pendant la grossesse et I'allaitement.
Source
Official Health Canada record, licence 80037907
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging